Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia

To translate and linguistically validate the Assessment of Quality of Life 8-dimensions (AQoL-8D) for use in the Netherlands and to compare the psychometric properties of AQoL-8D with the EuroQol 5-dimensions 5-levels (EQ-5D-5L) in two patient samples. AQoL-8D was translated from English into Dutch. The translated AQoL-8D was then administered alongside the EQ-5D-5L at baseline and follow-up of two Dutch randomized controlled trials among patients with epilepsy and schizophrenia. These data were subjected to a post-hoc analysis assessing the psychometric properties of AQol-8D vis-à-vis EQ-5D-5... Mehr ...

Verfasser: Hoi Yau Chan (5954270)
Ben F. M. Wijnen (4997315)
Mickaël Hiligsmann (3331467)
Filip Smit (186016)
Loes A. M. Leenen (11501402)
Marian H. J. M. Majoie (11501405)
Silvia M. A. A. Evers (7411607)
Dokumenttyp: Text
Erscheinungsdatum: 2021
Schlagwörter: Neuroscience / Physiology / Sociology / Mental Health / Space Science / Biological Sciences not elsewhere classified / Validity / EuroQoL-5D / AQoL-8D / responsiveness / quality of life / utility
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-27438326
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.6084/m9.figshare.16669329.v2

To translate and linguistically validate the Assessment of Quality of Life 8-dimensions (AQoL-8D) for use in the Netherlands and to compare the psychometric properties of AQoL-8D with the EuroQol 5-dimensions 5-levels (EQ-5D-5L) in two patient samples. AQoL-8D was translated from English into Dutch. The translated AQoL-8D was then administered alongside the EQ-5D-5L at baseline and follow-up of two Dutch randomized controlled trials among patients with epilepsy and schizophrenia. These data were subjected to a post-hoc analysis assessing the psychometric properties of AQol-8D vis-à-vis EQ-5D-5L in terms of known-groups construct validity, responsiveness, and floor/ceiling effects. In total, 103 epilepsy patients and 99 schizophrenia patients were included in this study. In both datasets, the two instruments discriminated between known-groups, but in schizophrenia, AQoL-8D showed higher responsiveness than EQ-5D-5L, while both instruments showed equal responsiveness in epilepsy. Ceiling effects were only found for EQ-5D-5L in both epilepsy (26.6%) and schizophrenia (6.1%). Our results have shown that, among other things, AQoL-8D presents better ability to discriminate between known-groups and shows no ceiling effect. Based on our results, we would recommend the use of AQoL-8D in addition to EQ-5D-5L in trials assessing patient’s quality of life in patients with epilepsy or schizophrenia.